Assembly Biosciences (ASMB) Change in Accured Expenses (2010 - 2026)

Assembly Biosciences' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$5.1 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 11.51% year-over-year to -$5.1 million; the TTM figure through Mar 2026 stood at $362000.0 (up 44.22% YoY), while the FY2025 annual figure was $887000.0, down 20.66% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$5.1 million, down from $2.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.3 million in Q3 2025, with the low at -$5.1 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is $1.1 million (2025), against an average of -$246647.1.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses plunged 131.79% in 2023, then surged 490.07% in 2024.
• Assembly Biosciences' Change in Accured Expenses stood at $1.6 million in 2022, then gained by 13.29% to $1.9 million in 2023, then rose by 12.86% to $2.1 million in 2024, then fell by 3.62% to $2.0 million in 2025, then slumped by 351.61% to -$5.1 million in 2026.
• Business Quant data shows ASMB's Change in Accured Expenses at -$5.1 million in Q1 2026, $2.0 million in Q4 2025, and $2.3 million in Q3 2025.